The DOJ had been investigating the off-label use of Infuse. Physicians are able to use products off label, but companies cannot promote off-label use.
More Articles on Orthopedic Devices:
Future of Orthopedic Instrumentation Industry Examined in New Report
20 Orthopedic Device Company Q1 Financial Report Updates
Mazor Revenue Up in Q1 After 3 Robotic Spine System Sales
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
